{
  "id": 16203184,
  "title": "Lycia's $318M IPO; Merck sac-TMT trial stopped early",
  "url": "https://urgent.news/2026/10/23/lycias-318m-ipo-merck-sac-tmt-trial-stopped-early",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-10-23T15:13:11.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lycias-318m-ipo-merck-sac-tmt-trial-stopped-early/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Hexagon Bio, Mineralys Therapeutics and Arbor Biotechnologies. Lycia prices $317.5 million IPO: Lycia Therapeutics, a company founded by Nobel Prize winner Carolyn Bertozzi, is pricing its initial public ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}